HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of arsenic on the topology and solubility of promyelocytic leukemia (PML)-nuclear bodies.

Abstract
Promyelocytic leukemia (PML) proteins are involved in the pathogenesis of acute promyelocytic leukemia (APL). Trivalent arsenic (As3+) is known to cure APL by binding to cysteine residues of PML and enhance the degradation of PML-retinoic acid receptor α (RARα), a t(15;17) gene translocation product in APL cells, and restore PML-nuclear bodies (NBs). The size, number, and shape of PML-NBs vary among cell types and during cell division. However, topological changes of PML-NBs in As3+-exposed cells have not been well-documented. We report that As3+-induced solubility shift underlies rapid SUMOylation of PML and late agglomeration of PML-NBs. Most PML-NBs were toroidal and granular dot-like in GFPPML-transduced CHO-K1 and HEK293 cells, respectively. Exposure to As3+ and antimony (Sb3+) greatly reduced the solubility of PML and enhanced SUMOylation within 2 h in the absence of changes in the number and size of PML-NBs. However, the prolonged exposure to As3+ and Sb3+ resulted in agglomeration of PML-NBs. Exposure to bismuth (Bi3+), another Group 15 element, did not induce any of these changes. ML792, a SUMO activation inhibitor, reduced the number of PML-NBs and increased the size of the NBs, but had little effect on the As3+-induced solubility change of PML. These results warrant the importance of As3+- or Sb3+-induced solubility shift of PML for the regulation intranuclear dynamics of PML-NBs.
AuthorsSeishiro Hirano, Osamu Udagawa
JournalPloS one (PLoS One) Vol. 17 Issue 5 Pg. e0268835 ( 2022) ISSN: 1932-6203 [Electronic] United States
PMID35594310 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Promyelocytic Leukemia Protein
  • Transcription Factors
  • Arsenic
Topics
  • Arsenic (metabolism, pharmacology)
  • Cell Nucleus (metabolism)
  • HEK293 Cells
  • Humans
  • Leukemia, Promyelocytic, Acute (metabolism)
  • Nuclear Bodies (chemistry)
  • Promyelocytic Leukemia Protein (genetics, metabolism)
  • Solubility
  • Transcription Factors (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: